Sorafenib to Treat FLT3-ITD AML
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene
- Status
- COMPLETED
- Phase
- PHASE1
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
- Status
- TERMINATED
- Phase
- PHASE1
Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- NA
Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment
- Status
- COMPLETED
- Phase
- NA
Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
- Status
- COMPLETED
- Phase
- PHASE2
Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
- Status
- UNKNOWN
- Phase
- PHASE3
A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Adoptive Transfer of Haplo-identical DLI for AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1